SABRINA PRIJATEL: Open Payments
NPI 1053913541 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 54 payments from 12 companies in 2025. Trend: 2023 $1,015 · 2024 $1,154 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 33 | $459 |
| Hologic Sales and Service, LLC | 4 | $92 |
| ViiV Healthcare Company | 3 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| ABBVIE INC. | 3 | $54 |
| GENZYME CORPORATION | 1 | $46 |
| Exact Sciences Corporation | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: APTIMA, APRETUDE, XIFAXAN, UBRELVY, DUPIXENT, SPRAVATO, SHINGRIX, Ozempic.
Industry payments across CA — which companies pay providers there.
